AIM IMMUNOTECH INC. Sale of Stock, Consideration Received on Transaction
AIM IMMUNOTECH INC. (AIM) reported Sale of Stock, Consideration Received on Transaction of $2.49 million for the 12-month period ending 2019-12-31, per its 10-K filed 2020-03-30.
Discontinued › Notes › Equity
us-gaap:SaleOfStockConsiderationReceivedOnTransaction · last filed 2020-03-30
- AIM IMMUNOTECH INC. sale of stock, consideration received on transaction for fiscal 2019 was $2.49M, a 210.09% increase from fiscal 2018.
- AIM IMMUNOTECH INC. sale of stock, consideration received on transaction for fiscal 2018 was $803.00K, a 238.82% increase from fiscal 2017.
- AIM IMMUNOTECH INC. sale of stock, consideration received on transaction for fiscal 2017 was $237.00K, a 36.21% increase from fiscal 2016.
- AIM IMMUNOTECH INC. sale of stock, consideration received on transaction for fiscal 2016 was $174.00K, a 98.20% decline from fiscal 2015.
| Period end | Sale of Stock, Consideration Received on Transaction 0 month | Sale of Stock, Consideration Received on Transaction 0 month as first filed | Sale of Stock, Consideration Received on Transaction 12 month |
|---|---|---|---|
| 2019-12-31 | $2.49M 10-K · filed 2020-03-30 | ||
| 2018-12-31 | $803.00K 10-K · filed 2020-03-30 | ||
| 2018-03-24 | $1.25M 10-Q · filed 2019-05-15 | $1.25B 10-Q · filed 2018-05-15 | |
| 2017-12-31 | $237.00K 10-K · filed 2019-04-01 | ||
| 2016-12-31 | $174.00K 10-K · filed 2018-03-30 | ||
| 2015-12-31 | $9.68M 10-K · filed 2018-03-30 |
Similar stocks
| Stock Name | Country | Market Cap | PE Ratio |
|---|---|---|---|
| CREATIVE MEDICAL TECHNOLOGY HOLDINGS, INC. (CELZ) | United States | $0.006B | |
| CERO THERAPEUTICS HOLDINGS, INC. (CERO) | United States | $0.007B | |
| PharmaCyte Biotech, Inc. (PMCB) | United States | $0.005B | |
| TScan Therapeutics, Inc. (TCRX) | United States | $0.008B | -1.23 |
| WINDTREE THERAPEUTICS INC /DE/ (WINT) | United States | $0.003B | -0.32 |
| VivoSim Labs, INC. (VIVS) | United States | $0.003B | |
| Calidi Biotherapeutics, Inc. (CLDI) | United States | $0.003B | |
| CURIS INC (CRIS) | United States | $0.002B | -0.05 |
| Senti Biosciences Holdings, Inc. (SNTI) | United States | $0.011B | -0.70 |
| Silexion Therapeutics Corp (SLXN) | $0.001B |